HuagongsheHuagongshe Chemistry Print Report · For research reference only
Triethylamine → N-((2'-Cyano(1,1'-biphenyl)-4-yl)methyl)-N-(1-oxopentyl)-L-valine methyl ester
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Valeryl chloride | HCID 61186 | — |
| Reactant | N-((2'-Cyano(1,1'-biphenyl)-4-yl)methyl)-L-valine methyl ester | HCID 16744794 | — |
| Reactant | HCID 178447302 | HCID 178447302 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | N-((2'-Cyano(1,1'-biphenyl)-4-yl)methyl)-N-(1-oxopentyl)-L-valine methyl ester | HCID 16744795 | — |
Reaction Steps
Briefly, the process for the preparation of valsartan comprises of the condensation of N-[(2′-cyanobiphenyl-4-yl)methyl]-(L)-valine methyl ester of Formula II with valeryl chloride of Formula III in the presence of triethylamine and dichloromethane, followed by flash chromatography, to give the compound N-[(2′-cyanobiphenyl-4-yl)methyl]-N-valeryl-(L)-valine methyl ester of Formula IV. The compound of Formula IV on tetrazole formation using tributyltin azide and subsequent hydrolysis using sodium hydroxide, followed by flash chromatography, gives valsartan of Formula I.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07659406B2 |
| Source dataset | uspto-grants-2010_02 |
| ORD ID | ord-cc81514b625a4b96bffa630fcbe18e96 |
| Source note | uspto-grants-2010_02 |